Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jun 14, 2011


NobleGen has disclosed several appointments to its board of directors and scientific advisory board.

Wolfgang Oster was appointed chairman of the board last September. He is the co-founder of Hemacon, Immunogenes, and Oncoceutics. He has held positions at PolyTechnos Venture-Partners and US BioScience. He holds an MD and PhD in internal medicine and hematology and oncology from Brown University and Germany's University of Freiburg.

Gavriel Meron was appointed to the board of directors in March. He is the chairman and CEO of MGD Management Services and Investments. Previously, he founded and served as CEO of Given Imaging, and was CEO of Applitec. He holds a BA in economics and statistics from Hebrew University of Jerusalem.

Chandra Venkatraman
joined the board of directors in April. He has over 30 years experience in digital signal processing and communications, including over 10 patents in the area. Venkatraman was previously a senior scientist at Hewlett-Packard, the founder and chairman of Arula, and held positions at the Tata Institute. He holds an MS in electrical engineering from Concordia University in Montreal, and a BS in electrical engineering from Bangalore University.

George Church joined NobleGen's scientific advisory board in January. He is the director of the Harvard Center for Computational Genetics and a professor of genetics at Harvard Medical School.

Chad Nusbaum
was appointed to the scientific advisory board in September. He is the head of sequencing operations at the Broad Institute. He holds a PhD in biology from MIT.

Zhiping Weng joined the scientific advisory board last June. He is a professor of molecular pharmacology and the director of the Center of Informatics and Integrative Biology at the University of Massachusetts Medical School. He holds a PhD in biomedical engineering from Boston University and a BS in electrical engineering from the University of Science and Technology of China.

Jorge Leon joined the scientific advisory board in February. He has held management positions at Quest Diagnostics and also founded Leomics Associates. He holds a PhD in cellular and molecular biology from New York University.

The Scan

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.

Study Looks at Parent Uncertainties After Children's Severe Combined Immunodeficiency Diagnoses

A qualitative study in EJHG looks at personal, practical, scientific, and existential uncertainties in parents as their children go through SCID diagnoses, treatment, and post-treatment stages.

Antimicrobial Resistance Study Highlights Key Protein Domains

By screening diverse versions of an outer membrane porin protein in Vibrio cholerae, researchers in PLOS Genetics flagged protein domain regions influencing antimicrobial resistance.

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.